Proof of Concept of Single Application of AL-60371/AL-817 Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes Compared to CIPRODEX® (BID for 7 Days)

Trial Profile

Proof of Concept of Single Application of AL-60371/AL-817 Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes Compared to CIPRODEX® (BID for 7 Days)

Discontinued
Phase of Trial: Phase II

Latest Information Update: 08 Dec 2017

At a glance

  • Drugs Finafloxacin/AL 817 (Primary) ; Ciprofloxacin/dexamethasone
  • Indications Bacterial infections; Otorrhoea
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 27 Aug 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 28 Apr 2014 Planned End Date changed from 1 Apr 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.
    • 20 Jan 2014 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top